INE361B01024
INE361B01024
DIVI S LABORATORIES LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 2.48T EUR | 1.75T EUR | 1.58T EUR |
Enterprise Value | 2.45T EUR | 1.75T EUR | 1.58T EUR |
Valuation Multiples | |||
Trailing P/E | 84.94x | 62.85x | 62.13x |
Forward P/E | 61.81x | -- | -- |
Price to Sales | 22.08x | 16x | 15.14x |
Price to Book | 14.79x | -- | 9.42x |
EV/Revenue | 21.84x | 16x | 15.12x |
EV/EBITDA | 61.85x | 41.28x | 40.58x |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -- | -- | -- |